US2008219946A1PendingUtilityA1
Therapeutic agent and method for ovulation disorder caused by luteinized unruptured follicle
Est. expiryMar 5, 2027(~0.6 yrs left)· nominal 20-yr term from priority
Inventors:Satoru Makinoda
A61P 43/00A61K 38/193A61K 38/00A61P 15/08
29
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A therapeutic agent for ovulation disorder of the present invention is characterized in comprising Granulocyte colony-stimulating factor; and that the ovulation disorder is caused by Luteinized Unruptured Follicle.
Claims
exact text as granted — not AI-modified1 . A therapeutic agent for ovulation disorder,
comprising Granulocyte colony-stimulating factor; wherein, the ovulation disorder is caused by Luteinized Unruptured Follicle.
2 . The therapeutic agent according to claim 1 , wherein the Luteinized Unruptured Follicle is caused by a fertility drug.
3 . The therapeutic agent according to claim 2 , wherein the fertility drug is Clomiphene or pharmaceutically acceptable salt thereof.
4 . The therapeutic agent according to claim 1 , wherein a form of the agent is injectable solution.
5 . A method for treating ovulation disorder, comprising the step of administering the therapeutic agent according to claim 1 .Join the waitlist — get patent alerts
Track US2008219946A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.